Page last updated: 2024-08-22

trimetazidine and Cardiomegaly

trimetazidine has been researched along with Cardiomegaly in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Hang, WJ; Peng, YZ; Shen, L; Shu, HY; Wang, DW; Zhang, M; Zhou, N1
Ahangarpour, A; Badavi, M; Dianat, M; Mard, SA; Ramezani-Aliakbari, F1
Mansur, AJ1
Gai, Y; Gao, W; Li, Z; Liu, F; Liu, X; Xu, M; Zhang, Y1
Allard, MF; Bescond-Jacquet, A; Grist, M; Lucien, A; Saeedi, R; Wambolt, RB1
Guarnieri, C; Muscari, C1

Other Studies

6 other study(ies) available for trimetazidine and Cardiomegaly

ArticleYear
Trimetazidine enhances myocardial angiogenesis in pressure overload-induced cardiac hypertrophy mice through directly activating Akt and promoting the binding of HSF1 to VEGF-A promoter.
    Acta pharmacologica Sinica, 2022, Volume: 43, Issue:10

    Topics: Angiogenesis Inducing Agents; Animals; Cardiomegaly; Heat Shock Transcription Factors; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Norepinephrine; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Transcription Factors; Trimetazidine; Vascular Endothelial Growth Factor A

2022
The Effects of Trimetazidine on QT-interval Prolongation and Cardiac Hypertrophy in Diabetic Rats.
    Arquivos brasileiros de cardiologia, 2019, Volume: 112, Issue:2

    Topics: Animals; Cardiomegaly; Catalase; Diabetes Complications; Diabetes Mellitus, Experimental; Echocardiography; Glutathione Peroxidase; Hemodynamics; Long QT Syndrome; Male; Protective Agents; Random Allocation; Rats, Sprague-Dawley; Reproducibility of Results; Superoxide Dismutase; Time Factors; Trimetazidine

2019
Cardiac Effects of Trimetazidine in Diabetic Rats.
    Arquivos brasileiros de cardiologia, 2019, Volume: 112, Issue:2

    Topics: Animals; Cardiomegaly; Diabetes Mellitus, Experimental; Heart; Long QT Syndrome; Rats; Trimetazidine

2019
Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway.
    Cardiovascular research, 2010, Oct-01, Volume: 88, Issue:1

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cell Proliferation; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Fibroblasts; Fibrosis; Hypertension; Male; Malondialdehyde; Myocardium; NADPH Oxidases; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Time Factors; Trimetazidine; Vasodilator Agents

2010
Trimetazidine normalizes postischemic function of hypertrophied rat hearts.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 314, Issue:1

    Topics: Adenosine Triphosphate; Animals; Cardiomegaly; Coronary Circulation; Glucose; Glycolysis; Kinetics; Lactic Acid; Male; Myocardial Contraction; Myocardial Ischemia; Myocardium; Oxidation-Reduction; Palmitates; Perfusion; Protons; Rats; Rats, Sprague-Dawley; Trimetazidine; Vasodilator Agents

2005
Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle of monocrotaline-treated rats.
    Biochemical pharmacology, 1988, Dec-15, Volume: 37, Issue:24

    Topics: Animals; Cardiomegaly; Electron Transport; Lipid Peroxides; Male; Mitochondria, Heart; Monocrotaline; Oxidative Phosphorylation; Oxygen Consumption; Piperazines; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Superoxides; Trimetazidine

1988